Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
August 2
 · 
Reactions

Answer Summary

Members responded to a question about skipping stem cell transplant (SCT) for multiple myeloma and relying on medication instead, with many... Read more

Members responded to a question about skipping stem cell transplant (SCT) for multiple myeloma and relying on medication instead, with many sharing that newer drug combinations, especially those including Daratumumab (Darzalex), have made SCT less necessary for some patients. Several members described reaching complete remission or MRD-negative status without SCT, while others shared positive SCT outcomes, with a common thread being that treatment decisions depend heavily on individual risk level, response to induction therapy, and oncologist guidance. A recurring theme was hope, as advances in treatment continue to improve outcomes and quality of life for many living with multiple myeloma.

A MyMyelomaTeam Member

Everyone is different with both their physical conditions ,age , case severity, and multiple myeloma type. I have IgA Kappa Light Chain multiple myeloma since 2019, was on RVD protocol and now in complete response Revlimid maintenance. I have never relapsed , but side effects from multiple myeloma and Revlimid always present in one form or another. I am not MRD negative but am looking to head in that direction .Your decision should be made with your healthcare team as they are familiar with your medical health. I hope you can find a direction to take.

August 2
A MyMyelomaTeam Member

Many Hematologists are not recommending SCT for Standard risk, because the new Quad drugs are doing just as good of a job controlling MM, and they don’t wipe out your immune system like SCT.
Paula🌹

August 2
A MyMyelomaTeam Member

My Johns Hopkins Consulting Onc, in 2021, told me to get DarzFasPro, before it was the FDA Standard of Care for First Line Treatment.

He said DarzFasPro will provide for a Faster and Deeper Complete Remission and that the First Remission is the Most Important, saying that subsequent Remissions are less likely to last.

For me, he was Right and I know of many others that have had the same experience as me, based on DarzFasPro as part of their First Line Treatment.

August 5
A MyMyelomaTeam Member

There are studies now that suggest patients with standard risk disease, that get a complete response to induction, can go to maintenance and keep transplant in reserve for later. But, for those of us that did not get a complete response to induction, stem cell transplant is still a good option. I had one in 2017. I am not mrd negative, but have done well on a two drug maintenance plan.

August 5
A MyMyelomaTeam Member

This question comes up a lot on here, especially with new patients. The short story is SCT was, and probably still is, the gold bar standard after induction therapy as it has a long history and track record. That being said, the advances in MM treatments, new drugs, and new drug combinations over the past 5 years has been amazing- and very effective. Now drs aren’t always pushing people towards invasive SCT but to other treatments. For me, the safe bet was to harvest and freeze my stem cells just in case I needed them for future use. You can freeze them for at least 10 years.

August 5

Related Questions

View All
A MyMyelomaTeam Member asked a question 💭
Lake Charles, LA